Works matching DE "GENZYME Corp."

Results: 85

Alfimeprase to succeed Genentech's alteplase?

Published in:

Nature Biotechnology, 2006, v. 24, n. 8, p. 875, doi. 10.1038/nbt0806-875

By:

Vastag, Brian

Publication type:

Article

News In Brief.

Published in:

Nature Biotechnology, 2006, v. 24, n. 2, p. 123, doi. 10.1038/nbt0206-123

By:

Coukell, Allan;
Lawrence, Stacy;
Sheridan, Cormac;
Vastag, Brian;
Vermij, Peter;
Waltz, Emily

Publication type:

Article

Biotechs sue Columbia over fourth Axel patent.

Published in:

Nature Biotechnology, 2003, v. 21, n. 9, p. 955, doi. 10.1038/nbt0903-955

By:

Howard, Ken

Publication type:

Article

News In Brief.

Published in:

Nature Biotechnology, 2003, v. 21, n. 9, p. 961, doi. 10.1038/nbt0903-961

By:

Basu, Paroma;
Bouchie, Aaron;
Defrancesco, Laura;
Depalma, Angelo;
Fox, Jeffrey L.;
Jia, Hepeng;
Louët, Sabine;
Norrie., Cheryl

Publication type:

Article

Internet chat damages biotechnology stocks.

Published in:

Nature Biotechnology, 2000, v. 18, n. 10, p. 1030, doi. 10.1038/80201

By:

Niiler, Eric

Publication type:

Article

Merger terminated.

Published in:

Nature Biotechnology, 2000, v. 18, n. 2, p. 132, doi. 10.1038/72499

By:

Niiler, Eric

Publication type:

Article

Genzyme acquires Cell Genesys.

Published in:

Nature Biotechnology, 1999, v. 17, n. 12, p. 1151, doi. 10.1038/70688

By:

Niiler, Eric

Publication type:

Article

Hypothetical biotechnology mega-mergers.

Published in:

Nature Biotechnology, 1999, v. 17, p. 8, doi. 10.1038/9082

By:

Persidis, Aris

Publication type:

Article

Billion-dollar bid for stem-cell treatments.

Published in:: Nature, 2008, v. 456, n. 7219, p. 153, doi. 10.1038/456153c
Publication type:: Article

Acknowledgements.

Published in:: Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_9, p. ix63, doi. 10.1093/ndt/gfm803
Publication type:: Article

Adopting Solutions to Orphan Drug Shortages.

Published in:

U.C. Davis Law Review, 2015, v. 48, n. 5, p. 2077

By:

Helen Liu

Publication type:

Article

Industry spotlight.

Published in:: Medical Laboratory Observer (MLO), 2004, v. 36, n. 7, p. 50
Publication type:: Article

SPONSORS.

Published in:: Nephrology, 2006, v. 11, p. iv, doi. 10.1111/j.1440-1797.2006.00658_2.x
Publication type:: Article

Plerixafor.

Published in:: Drugs in R&D, 2007, v. 8, n. 2, p. 113, doi. 10.2165/00126839-200708020-00006
Publication type:: Article

Alpha-Galactosidase - Genzyme General: Fabrazyme®, Agalsidase Beta, Recombinant Human α-Galactosidase A.

Published in:: Drugs in R&D, 2003, v. 4, n. 2, p. 115, doi. 10.2165/00126839-200304020-00006
Publication type:: Article

Adventitious Viral Contamination of Biopharmaceuticals: Who is at Risk?

Published in:

BioProcessing Journal, 2011, v. 10, n. 1, p. 4, doi. 10.12665/J101.Nims

By:

Nims, Raymond

Publication type:

Article

Study Probes Best Choice of Drug to Reduce Phosphate in Patients on Dialysis.

Published in:

JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 1995, doi. 10.1001/jama.298.17.1995

By:

Mitka, Mike

Publication type:

Article

Legal and regulatory update.

Published in:: Journal of Commercial Biotechnology, 2003, v. 10, n. 1, p. 92, doi. 10.1057/palgrave.jcb.3040059
Publication type:: Article

Co-Defense and Attack on Clinical Trials.

Published in:

Applied Clinical Trials, 2005, v. 14, n. 11, p. 28

By:

O'Donnell, Peter

Publication type:

Article

Aubagio on PBS.

Published in:: 2014
Publication type:: Product Review

Consensus recommendations.

Published in:

2007

By:

Beutler, Ernest

Publication type:

Editorial

Pharmaceutical; trademark; patents; news.

Published in:

Journal of Generic Medicines, 2011, v. 8, n. 2, p. 117, doi. 10.1177/1741134311413530

By:

Milchior, R;
Charbonnel, S;
Benattar, E

Publication type:

Article

At last: Genzyme falls to sanofi aventis.

Published in:

Chemistry & Industry, 2011, n. 5, p. 5

By:

Dorey, Emma

Publication type:

Article

Genzyme faces $175m FDA fines.

Published in:

Chemistry & Industry, 2010, n. 9, p. 5

By:

Dorey, Emma

Publication type:

Article

News in brief.

Published in:: Chemistry & Industry, 2008, n. 23, p. 9
Publication type:: Article

Genzyme deal.

Published in:: Chemistry & Industry, 2008, n. 15, p. 5
Publication type:: Article

Business Digest.

Published in:

Chemistry & Industry, 2008, n. 2, p. 13

By:

Eisberg, Neil

Publication type:

Article

Business Digest.

Published in:

Chemistry & Industry, 2007, n. 21, p. 13

By:

Eisberg, Neil

Publication type:

Article

News briefs.

Published in:: Chemistry & Industry, 2007, n. 18, p. 6
Publication type:: Article

Business Digest.

Published in:: Chemistry & Industry, 2007, n. 5, p. 14
Publication type:: Article

Business Digest.

Published in:

Chemistry & Industry, 2006, n. 24, p. 14

By:

Eisberg, Neil

Publication type:

Article

News Blast.

Published in:: Bio-IT World, 2006, v. 5, n. 2, p. 24
Publication type:: Article

Guerilla Informatics -- Genzyme Style.

Published in:

Bio-IT World, 2006, v. 5, n. 2, p. 12

By:

Russell, John

Publication type:

Article

Biotech Beckons in Bonny Scotland.

Published in:

Bio-IT World, 2005, v. 4, n. 10, p. 46

By:

Jack, Lorna

Publication type:

Article

RECOMBINATION.

Published in:: Bio-IT World, 2003, v. 2, n. 9, p. 22
Publication type:: Article

Banking on the future: Biobanking human blood and tissue advances cancer research.

Published in:

2014

By:

Printz, Carrie

Publication type:

Other

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2009, v. 66, n. 18, p. 1599
Publication type:: Article

Timeline of events: A brief history of what made news this year.

Published in:: Nature Medicine, 2011, v. 17, n. 12, p. 1543, doi. 10.1038/nm1211-1543
Publication type:: Article

March on, not in.

Published in:: 2011
Publication type:: Editorial

NIH faces marching orders on orphan drug shortage.

Published in:

Nature Medicine, 2011, v. 17, n. 5, p. 522, doi. 10.1038/nm0511-522b

By:

Dolgin, Elie

Publication type:

Article

Genzyme, though unique, could be a bellwether for US biotech.

Published in:

Nature Medicine, 2011, v. 17, n. 2, p. 145, doi. 10.1038/nm0211-145

By:

Dolgin, Elie

Publication type:

Article

Movers & Shakers.

Published in:: Chemistry & Industry, 2003, n. 6, p. 30
Publication type:: Article

Announcements.

Published in:: Oncology (08909091), 2007, v. 21, n. 11, p. 1322
Publication type:: Article

Alemtuzumab Appears Safe, Effective, Even in Poor-Prognosis Leukemia Patients.

Published in:: Oncology (08909091), 2006, v. 20, n. 10, p. 1132
Publication type:: Article

Market watch: Upcoming market catalysts in Q4 2011.

Published in:

Nature Reviews Drug Discovery, 2011, v. 10, n. 10, p. 723, doi. 10.1038/nrd3564

By:

Tucker, John

Publication type:

Article

Regulatory Affairs.

Published in:: 2009
Publication type:: Interview

News in brief.

Published in:: Nature Reviews Drug Discovery, 2008, v. 7, n. 6, p. 466, doi. 10.1038/nrd2611
Publication type:: Article

Joanna F. Haas.

Published in:: 2005
Publication type:: Interview

Patent Watch.

Published in:: Nature Reviews Drug Discovery, 2003, v. 2, n. 9, p. 690, doi. 10.1038/nrd1188
Publication type:: Article

Society News.

Published in:: American Journal of Sports Medicine, 2010, v. 38, n. 4, p. 842, doi. 10.1177/0363546510368053
Publication type:: Article